연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2277. Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML.
Jeong D1, Lee DS2, Kim N1, Choi S3, Kim K3, Kim SM4, Im K4, Park HS5, Yun J1, Lim KM4, Park KS6, Kang HJ7, Ahn YO4, Hwang SM8.
Leuk Res. 2019 Oct;85:106210. doi: 10.1016/j.leukres.2019.106210. Epub 2019 Aug 12.
Link
2276. Expression of SLC5A5 in Circulating Tumor Cells May Distinguish Follicular Thyroid Carcinomas from Adenomas: Implications for Blood-Based Preoperative Diagnosis.
Jee HG, Kim BA, Kim M, Yu HW, Choi JY, Kim SJ, Lee KE.
Journal of clinical medicine. 2019 Feb;8(2):257.
Link
2275. Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer.
Choi M1, Han J2, Yang BR2, Jang MJ2, Kim M1,3, Kim TY1,3, Im SA1,3, Lee HB4, Moon HG4, Han W4, Noh DY4, Lee KH5,3.
Oncologist. 2019 Dec;24(12):e1268-e1276. doi: 10.1634/theoncologist.2019-0167. Epub 2019 Jul 2.
Link
2274. Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
Kim JY1,2, Lee DW3, Lee KH4,5,6, Min A1,2, Ryu HS7, Lee HB1,8, Moon HG1,8, Kim TY1,2,3, Han SW1,2,3, Oh DY1,2,3, Han W1,8, Park IA7, Noh DY1,8, Im SA1,2,3, Kim S9.
Breast Cancer Res Treat. 2019 Jul;176(2):453-460. doi: 10.1007/s10549-019-05249-1. Epub 2019 Apr 26.
Link
2273. Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients.
Lee DW1, Ryu HS2, Jin MS3, Lee KH4,5,6, Suh KJ7,8, Youk J1, Kim JY7,9, Min A7,9, Lee HB7,10, Moon HG7,10, Kim TY1,7,9, Han SW1,7,9, Oh DY1,7,9, Han W7,10, Park IA2, Noh DY7,10, Im SA11,12,13.
Br J Cancer. 2019 Jul;121(3):230-236. doi: 10.1038/s41416-019-0511-9. Epub 2019 Jul 11.
Link
2272. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Suh KJ1,2, Ryu HS3,4, Lee KH5,6, Kim H3, Min A4, Kim TY4,7, Yang Y1,8, Lee HB4,9, Moon HG4,9, Han SW4,7, Oh DY1,4,7, Han W4,9, Park IA3,4, Noh DY4,9, Im SA10,11,12.
Breast Cancer Res Treat. 2019 May;175(1):117-127. doi: 10.1007/s10549-019-05128-9. Epub 2019 Jan 22.
Link
2271. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
Yoo JJ1, Yu SJ2, Na J3, Kim K4, Cho YY5, Lee YB6, Cho EJ7, Lee JH8, Kim YJ9, Youn H10, Yoon JH11.
Int J Mol Sci. 2019 Mar 14;20(6). pii: E1292. doi: 10.3390/ijms20061292.
Link
2270. The Satisfaction with Life Scale and the Subjective Well-Being Inventory in the General Korean Population: Psychometric Properties and Normative Data.
Yun YH, Rhee YE, Kang E, Sim JA.
Mol Cancer Ther. 2018 Dec;17(12):2507-2518
Link
2269. Establishment of Normative Self-Rated Health Status Data and Association between Ideal Life Expectancy and Social Wellness of General Population in Korea.
Lee J, Sim JA, Kim JW, Yun YH
Asian Nurs Res (Korean Soc Nurs Sci). 2019 May;13(2):99-106.
Link
2268. Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial
Yun YH, Kang E, Park S, Koh SJ, Oh HS, Keam B, Do YR, Chang WJ, Jeong HS, Nam EM, Jung KH, Kim HR, Choo J, Lee J, Sim JA.
J Pain Symptom Manage. 2019 Dec;58(6):940-948.e2.
Link